Insight Molecular Diagnostics Basic Shares Outstanding 2014-2025 | IMDX

Insight Molecular Diagnostics basic shares outstanding from 2014 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
Insight Molecular Diagnostics Annual Basic Shares Outstanding
(Millions of US $)
2024 $13
2023 $8
2022 $6
2021 $4
2020 $3
2019 $3
2018 $2
2017 $2
2016 $1
2015 $1
2014 $1
2013 $1
Insight Molecular Diagnostics Quarterly Basic Shares Outstanding
(Millions of US $)
2025-03-31 $26
2024-12-31 $13
2024-09-30 $14
2024-06-30 $13
2024-03-31 $8
2023-12-31 $8
2023-09-30 $8
2023-06-30 $8
2023-03-31 $6
2022-12-31 $6
2022-09-30 $6
2022-06-30 $6
2022-03-31 $5
2021-12-31 $4
2021-09-30 $5
2021-06-30 $4
2021-03-31 $4
2020-12-31 $3
2020-09-30 $3
2020-06-30 $3
2020-03-31 $3
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $2
2018-12-31 $2
2018-09-30 $2
2018-06-30 $2
2018-03-31 $2
2017-12-31 $2
2017-09-30 $2
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.092B $0.002B
Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.313B 58.92
Tempus AI (TEM) United States $11.516B 0.00
Doximity (DOCS) United States $11.474B 53.12
Hims & Hers Health (HIMS) United States $11.060B 114.91
IRhythm Technologies (IRTC) United States $4.939B 0.00
Inspire Medical Systems (INSP) United States $3.905B 61.02
Hinge Health (HNGE) United States $3.629B 0.00
Privia Health (PRVA) United States $2.682B 183.33
Enovis (ENOV) United States $1.815B 10.12
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.444B 0.00
Clover Health Investments (CLOV) United States $1.405B 0.00
Azenta (AZTA) United States $1.400B 65.08
Omnicell (OMCL) United States $1.376B 24.28
Evolent Health (EVH) United States $1.310B 111.60
Claritev (CTEV) United States $0.716B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.452B 0.00
TruBridge (TBRG) United States $0.349B 773.33
Outset Medical (OM) United States $0.338B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.124B 0.00
MDxHealth SA (MDXH) Belgium $0.109B 0.00
Pulmonx (LUNG) United States $0.105B 0.00
CareCloud (CCLD) United States $0.102B 3.89
111 (YI) China $0.060B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.051B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00